In African-Americans, quantitative TNF-α levels were higher in sarcoidosis with neurologic disease compared to patients lacking this manifestation (P = 0.022) and to African-American controls (P = 0.0030, Figure 3), with the same patterns maintained when the few patients on TNF-α inhibitors were removed (Figure S1). Here, TNF is linked to nervous system disorder.